LifeStance Health Group, Inc. (NASDAQ:LFST) Receives Average Recommendation of “Moderate Buy” from Brokerages

LifeStance Health Group, Inc. (NASDAQ:LFST) has earned an average recommendation of “Moderate Buy” from the six brokerages that are presently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and four have given a buy recommendation to the company. The average 1 year price target among brokerages that have covered the stock in the last year is $8.50.

A number of equities research analysts recently commented on the stock. William Blair reissued an “outperform” rating on shares of LifeStance Health Group in a research note on Friday, February 28th. Canaccord Genuity Group assumed coverage on shares of LifeStance Health Group in a research note on Thursday, April 3rd. They set a “buy” rating and a $8.00 price objective for the company. Finally, The Goldman Sachs Group raised LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 target price on the stock in a research note on Monday, December 16th.

LifeStance Health Group Stock Down 2.0 %

LifeStance Health Group stock opened at $6.51 on Thursday. The firm has a market capitalization of $2.50 billion, a price-to-earnings ratio of -25.04 and a beta of 1.30. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.32 and a current ratio of 1.32. LifeStance Health Group has a fifty-two week low of $4.64 and a fifty-two week high of $8.61. The stock’s fifty day moving average is $7.44 and its two-hundred day moving average is $7.34.

Insider Activity at LifeStance Health Group

In related news, insider Lisa K. Miller sold 18,845 shares of the company’s stock in a transaction on Monday, March 17th. The stock was sold at an average price of $6.90, for a total value of $130,030.50. Following the completion of the transaction, the insider now directly owns 339,810 shares in the company, valued at approximately $2,344,689. This represents a 5.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 6.60% of the company’s stock.

Institutional Trading of LifeStance Health Group

Several hedge funds and other institutional investors have recently added to or reduced their stakes in LFST. Blue Trust Inc. lifted its holdings in shares of LifeStance Health Group by 124.4% during the 4th quarter. Blue Trust Inc. now owns 3,828 shares of the company’s stock worth $27,000 after acquiring an additional 2,122 shares during the period. LPL Financial LLC boosted its holdings in shares of LifeStance Health Group by 6.0% in the 4th quarter. LPL Financial LLC now owns 37,584 shares of the company’s stock valued at $277,000 after purchasing an additional 2,127 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of LifeStance Health Group by 2.4% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 138,781 shares of the company’s stock valued at $1,023,000 after purchasing an additional 3,305 shares during the last quarter. MetLife Investment Management LLC grew its stake in shares of LifeStance Health Group by 6.8% during the 4th quarter. MetLife Investment Management LLC now owns 85,914 shares of the company’s stock valued at $633,000 after buying an additional 5,492 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of LifeStance Health Group by 31.4% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 24,105 shares of the company’s stock worth $169,000 after buying an additional 5,767 shares during the last quarter. Hedge funds and other institutional investors own 85.50% of the company’s stock.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.